Ita Brennan
Analyst · the Arista website following this call. I will now turn the call over to Mr. Curtis McKee, Director of Corporate and Investor Development. Sir, you may begin
Thanks, Jayshree and good afternoon. This analysis of our Q2 results and our guidance for Q3 2020 is based on non-GAAP and excludes all non-cash stock-based compensation impacts, certain acquisition-related charges and other non-recurring items. A full reconciliation of our selected GAAP to non-GAAP results is provided in our earnings release. Total revenues in Q2 were $541 million, down 11% year-over-year, but at the upper end of our guidance are $520 million to $540 million. Approximately, 6% of this decline related to the recognition of $38 million of product deferred revenue in the second quarter of 2019. In addition, while overall demand in Q2 was reasonably healthy, we continue to experience some COVID-19 related supply challenges, resulting in extended lead time and somewhat constrained shipments for the quarter. Service revenues represented approximately 22% of total revenues, up slightly from 21% last quarter. International revenue for the quarter came in at $104.7 million or 19.4% of total revenues, down from 23% in the first quarter. While the shift in geographical mix on a quarter-over-quarter and year-over-year basis was largely due to the location of deployments by our cloud titan customers, we did see some push-out of larger opportunities in our in-region businesses also. Overall, gross margin in Q2 was 64.7% above the midpoint of our guidance of approximately 63% to 65% compared to last quarter at 65.6%. Operating expenses for the quarter were $144.1 million or 26.7% in revenue, down from last quarter at $149.3 million. R&D spending came in at $91.6 million or 17% of revenue consistent with last quarter. Sales and marketing expense was $41.9 million or 7.8% of revenues, down from $46 million last quarter, with lower marketing and travel-related spending. Our G&A costs come in at $10.6 million or 2% of revenue, down from last quarter of approximately $12 million. Our operating income for the quarter was $205.7 million, or 38.1% of revenues. Other income and expense for the quarter was a favorable $8.3 million and our effective tax rate was approximately 21.9%. This resulted in net income for the quarter of $167 million, or 30.9% of revenue. Our diluted share number was 79.3 million shares resulting in a diluted earnings per share number for the quarter of $2.11, down 13.5% from the prior year. Now, turning to the balance sheet. Cash, cash equivalents and investments ended the quarter at approximately $2.8 billion. We did not repurchase shares of our common stock during the second quarter. As a reminder, we have previously repurchased $494 million or 2.4 million shares against our Board authorization to repurchase $1 billion worth of shares over 3 years commencing in Q2 ‘19. We expect to continue to execute opportunistically against the remaining authorization. We generated $138 million of cash from operations in the second quarter, reflecting solid net income performance somewhat offset by incremental working capital investments. We expect to continue to strategically increase inventory levels through the end of the year as we look to improve lead times and help buffer against any future COVID-related supply chain disruptions. DSOs came in at 65 days, up from 61 days in Q1, reflecting the linearity of billings in the period. Inventory turns were 2.3x, down from 2.5x last quarter. Inventory increased to $327 million in the quarter, up from $262 million in the prior period. Our total deferred revenue balance was $578 million, down from $597 million in Q1. As a reminder, our deferred revenue balance is now almost exclusively services related. The level of services deferred revenue is directly linked to the timing and term of service renewals, which can vary on a quarter-by-quarter basis. Accounts payable days were 59 days, up from 43 days in Q1, reflecting the timing of inventory receipts and payments. Capital expenditures for the quarter were $2.1 million. Now, turning to our outlook for the third quarter and beyond. We continue to closely monitor the impact of COVID-19 around the world. Local operating restrictions remain in flux and it is unclear when and how these restrictions will finally be resolved. While we made good progress on supply chain and manufacturing during the quarter, we still have some work to do to slowly return to normal lead times. On the gross margin front, we would reiterate our overall gross margin outlook of 63% to 65%, with customer mix being the key driver. We expect to recognize some incremental COVID related freight and supply chain costs in Q3 and Q4. With all other things being equal, we’d bound gross margins closer to the midpoint of our range. On the spending side, we will continue to manage spending and investments carefully, prioritizing key projects and customer engagements, while benefiting from a natural COVID-related reduction in travel, marketing and related expenses. You should, however, expect to see us add investments back into the model as incremental revenue solidifies. Finally, our guidance for Q3 reflects our current understanding of COVID-19 and its impact in our business and supply chain. This is however an inherently uncertain situation and we will need to continue to monitor and attempt to mitigate new challenges as the situation unfolds. With all of this as a backdrop, our guidance for the third quarter, which is based on non-GAAP results and excludes any non-cash stock-based compensation impacts and other non-recurring items, is as follows: revenues of approximately $570 million to $590 million, gross margin of 63% to 65%, operating margin of approximately 37%. Our effective tax rate is expected to be approximately 21.9%, with diluted shares of approximately 79.6 million shares. I will now turn the call back to Curtis. Curtis?